List of Excipients in API valganciclovir
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing valganciclovir
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | CELLULOSE, MICROCRYSTALLINE | |
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | CROSPOVIDONE | |
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | FERRIC OXIDE RED | |
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | HYPROMELLOSE 2910 | |
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | POLYETHYLENE GLYCOL 400 | |
| Genentech Inc | VALCYTE | valganciclovir | 0004-0038 | POLYSORBATE 80 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 6 of 6 entries
Excipients in ANDA-approved (generic) drugs containing valganciclovir
Showing 1 to 6 of 6 entries
Detailed excipient profiles for valganciclovir
Excipient focus: .ALPHA.-TOCOPHEROL
valganciclovir drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing .ALPHA.-TOCOPHEROL
Showing 1 to 6 of 6 entries
Excipient focus: ACACIA
valganciclovir drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing ACACIA
Showing 1 to 6 of 6 entries
Excipient focus: ANHYDROUS CITRIC ACID
valganciclovir drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| American Health Packaging | valganciclovir hydrochloride | 60687-765 |
| NorthStar RxLLC | valganciclovir hydrochloride | 72603-174 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
valganciclovir drug variants not containing ANHYDROUS CITRIC ACID
Showing 1 to 6 of 6 entries
Excipient focus: CELLULOSE, MICROCRYSTALLINE
valganciclovir drug variants containing CELLULOSE, MICROCRYSTALLINE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing CELLULOSE, MICROCRYSTALLINE
Showing 1 to 6 of 6 entries
Excipient focus: CROSPOVIDONE
valganciclovir drug variants containing CROSPOVIDONE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing CROSPOVIDONE
Showing 1 to 6 of 6 entries
Excipient focus: FERRIC OXIDE RED
valganciclovir drug variants containing FERRIC OXIDE RED
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing FERRIC OXIDE RED
Showing 1 to 6 of 6 entries
Excipient focus: FERRIC OXIDE YELLOW
valganciclovir drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir | 27241-158 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | valganciclovir | 0004-0038 |
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| NorthStar Rx LLC | valganciclovir | 16714-765 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| Safecor Health LLC | valganciclovir | 48433-124 |
| AvPAK | valganciclovir | 50268-787 |
| >Company | >Ingredient | >NDC |
Showing 1 to 6 of 6 entries
Excipient focus: FUMARIC ACID
valganciclovir drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| airis PHARMA PVT LTD | valganciclovir | 71151-003 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Novadoz Pharmaceuticals LLC | valganciclovir hydrochloride | 72205-019 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
valganciclovir drug variants not containing FUMARIC ACID
Showing 1 to 6 of 6 entries
Excipient focus: HYPROMELLOSE
valganciclovir drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | valganciclovir | 0004-0038 |
| NorthStar Rx LLC | valganciclovir | 16714-765 |
| Ajanta Pharma USA Inc | valganciclovir | 27241-158 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| Safecor Health LLC | valganciclovir | 48433-124 |
| AvPAK | valganciclovir | 50268-787 |
| >Company | >Ingredient | >NDC |
Showing 1 to 6 of 6 entries
Excipient focus: HYPROMELLOSE 2910
valganciclovir drug variants containing HYPROMELLOSE 2910
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing HYPROMELLOSE 2910
Showing 1 to 6 of 6 entries
Excipient focus: HYPROMELLOSES
valganciclovir drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| AvPAK | valganciclovir | 50268-787 |
| McKesson Corporation DBA SKY Packaging | valganciclovir | 63739-076 |
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
valganciclovir drug variants not containing HYPROMELLOSES
Showing 1 to 6 of 6 entries
Excipient focus: MAGNESIUM STEARATE
valganciclovir drug variants containing MAGNESIUM STEARATE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | valganciclovir | 0004-0038 |
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| Ajanta Pharma USA Inc | valganciclovir | 27241-158 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| AvPAK | valganciclovir | 50268-787 |
| H2-Pharma LLC | valganciclovir | 61269-480 |
| >Company | >Ingredient | >NDC |
Showing 1 to 6 of 6 entries
Excipient focus: MALTODEXTRIN
valganciclovir drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing MALTODEXTRIN
Showing 1 to 6 of 6 entries
Excipient focus: MANNITOL
valganciclovir drug variants containing MANNITOL
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing MANNITOL
Showing 1 to 6 of 6 entries
Excipient focus: OCTENYLSUCCINIC ACID
valganciclovir drug variants containing OCTENYLSUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing OCTENYLSUCCINIC ACID
Showing 1 to 6 of 6 entries
Excipient focus: POLYETHYLENE GLYCOL
valganciclovir drug variants containing POLYETHYLENE GLYCOL
Showing 1 to 5 of 5 entries
valganciclovir drug variants not containing POLYETHYLENE GLYCOL
Showing 1 to 6 of 6 entries
Excipient focus: POLYETHYLENE GLYCOL 400
valganciclovir drug variants containing POLYETHYLENE GLYCOL 400
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing POLYETHYLENE GLYCOL 400
Showing 1 to 6 of 6 entries
Excipient focus: POLYETHYLENE GLYCOL 4000
valganciclovir drug variants containing POLYETHYLENE GLYCOL 4000
Showing 1 to 5 of 5 entries
valganciclovir drug variants not containing POLYETHYLENE GLYCOL 4000
Showing 1 to 6 of 6 entries
Excipient focus: POLYETHYLENE GLYCOL 6000
valganciclovir drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | valganciclovir | 69097-277 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing POLYETHYLENE GLYCOL 6000
Showing 1 to 6 of 6 entries
Excipient focus: POLYSORBATE 80
valganciclovir drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | valganciclovir | 0004-0038 |
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| NorthStar Rx LLC | valganciclovir | 16714-765 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| Safecor Health LLC | valganciclovir | 48433-124 |
| AvPAK | valganciclovir | 50268-787 |
| >Company | >Ingredient | >NDC |
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing POLYSORBATE 80
Showing 1 to 6 of 6 entries
Excipient focus: POLYVINYL ALCOHOL
valganciclovir drug variants containing POLYVINYL ALCOHOL
Showing 1 to 5 of 5 entries
valganciclovir drug variants not containing POLYVINYL ALCOHOL
Showing 1 to 6 of 6 entries
Excipient focus: POVIDONE
valganciclovir drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| AvPAK | valganciclovir | 50268-787 |
| McKesson Corporation DBA SKY Packaging | valganciclovir | 63739-076 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
valganciclovir drug variants not containing POVIDONE
Showing 1 to 6 of 6 entries
Excipient focus: POVIDONE K30
valganciclovir drug variants containing POVIDONE K30
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing POVIDONE K30
Showing 1 to 6 of 6 entries
Excipient focus: PROPYLENE GLYCOL
valganciclovir drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | valganciclovir hydrochloride powder, | 59651-444 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing PROPYLENE GLYCOL
Showing 1 to 6 of 6 entries
Excipient focus: SACCHARIN SODIUM
valganciclovir drug variants containing SACCHARIN SODIUM
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing SACCHARIN SODIUM
Showing 1 to 6 of 6 entries
Excipient focus: SILICON DIOXIDE
valganciclovir drug variants containing SILICON DIOXIDE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing SILICON DIOXIDE
Showing 1 to 6 of 6 entries
Excipient focus: SODIUM BENZOATE
valganciclovir drug variants containing SODIUM BENZOATE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing SODIUM BENZOATE
Showing 1 to 6 of 6 entries
Excipient focus: STEARIC ACID
valganciclovir drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | valganciclovir | 0004-0038 |
| Major Pharmaceuticals | valganciclovir | 0904-6796 |
| Ajanta Pharma USA Inc | valganciclovir | 27241-158 |
| Camber Pharmaceuticals Inc | valganciclovir | 31722-832 |
| AvPAK | valganciclovir | 50268-787 |
| H2-Pharma LLC | valganciclovir | 61269-480 |
| >Company | >Ingredient | >NDC |
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing STEARIC ACID
Showing 1 to 6 of 6 entries
Excipient focus: SUCRALOSE
valganciclovir drug variants containing SUCRALOSE
Showing 1 to 5 of 5 entries
valganciclovir drug variants not containing SUCRALOSE
Showing 1 to 6 of 6 entries
Excipient focus: TALC
valganciclovir drug variants containing TALC
Showing 1 to 5 of 5 entries
valganciclovir drug variants not containing TALC
Showing 1 to 6 of 6 entries
Excipient focus: TARTARIC ACID
valganciclovir drug variants containing TARTARIC ACID
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing TARTARIC ACID
Showing 1 to 6 of 6 entries
Excipient focus: TITANIUM DIOXIDE
valganciclovir drug variants containing TITANIUM DIOXIDE
Showing 1 to 6 of 6 entries
valganciclovir drug variants not containing TITANIUM DIOXIDE
Showing 1 to 6 of 6 entries
Excipient focus: TRIACETIN
valganciclovir drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
valganciclovir drug variants not containing TRIACETIN
Showing 1 to 6 of 6 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
